Extension Study of Semapimod 60 mg IV x 3 Days

Clinical trial NCT00741910 · COMPLETED

Trial details

NCT number: NCT00741910
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2003-07-01
Primary completion: 2006-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.